ER+ and TN BC also differ in various biological aspects, such as immune responses (ER+ BC is often described as “immune cold”), metastatic tropism, and therapeutic options with an emphasis on antiestrogen treatment for ER+ BC. Here, ESR1 is linked to breast cancer.